Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders.

MLA

Kong, Wei-Jia, et al. “Berberine in the Treatment of Metabolism-Related Chronic Diseases: A Drug Cloud (DCloud) Effect to Target Multifactorial Disorders.” Pharmacology & Therapeutics, vol. 209, May 2020, p. 107496. EBSCOhost, https://doi.org/10.1016/j.pharmthera.2020.107496.

APA

Kong, W.-J., Vernieri, C., Foiani, M., & Jiang, J.-D. (2020). Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacology & Therapeutics, 209, 107496. https://doi.org/10.1016/j.pharmthera.2020.107496

Chicago

Kong, Wei-Jia, Claudio Vernieri, Marco Foiani, and Jian-Dong Jiang. 2020. “Berberine in the Treatment of Metabolism-Related Chronic Diseases: A Drug Cloud (DCloud) Effect to Target Multifactorial Disorders.” Pharmacology & Therapeutics 209 (May): 107496. doi:10.1016/j.pharmthera.2020.107496.